Christopher Thibodeau

Christopher Thibodeau

CEO and Executive Director, Vesica Health

Christopher brings 28 years of leadership experience in molecular diagnostics and oncology. Previously, he served as CEO of Immunis.AI, an immunogenomics platform company leveraging NGS and machine learning to develop assays for urologic cancers. As COO at MDxHealth, he played a key role in the company's growth, establishing US Operations, and leading the team initiatives that successfully delivered validation, guideline inclusion, Medicare reimbursement, and market adoption of the company’s urology & oncology tests and services. He has held leadership roles at Genuity Health, Agendia, Numira Biosciences, US LABS (acquired by LabCorp), and Ventana Medical Systems (acquired by Roche).